Diaceutics PLC (LON:DXRX – Get Free Report) shares traded down 1.6% during trading on Wednesday . The company traded as low as GBX 127 ($1.65) and last traded at GBX 127 ($1.65). 5,782 shares were traded during trading, a decline of 95% from the average session volume of 111,015 shares. The stock had previously closed at GBX 129 ($1.67).
Analyst Ratings Changes
Separately, Canaccord Genuity Group restated a “buy” rating and set a GBX 160 ($2.08) price target on shares of Diaceutics in a research report on Tuesday, September 17th.
View Our Latest Stock Analysis on DXRX
Diaceutics Stock Performance
Diaceutics Company Profile
Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics.
Read More
- Five stocks we like better than Diaceutics
- Want to Profit on the Downtrend? Downtrends, Explained.
- Texas Roadhouse Stock Steering for New Highs This Year
- Insider Buying Explained: What Investors Need to Know
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What is a support level?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Diaceutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diaceutics and related companies with MarketBeat.com's FREE daily email newsletter.